← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2011Last known activity
Sep 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 5 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (11)
- NCT07127237Lead sponsorEarly Phase 1Sep 30, 2025
- NCT07127237Sponsor investigatorEarly Phase 1Sep 30, 2025
- NCT05726344Lead sponsorN/AFeb 10, 2023
- NCT05726344Reponsible party - principal investigatorN/AFeb 10, 2023
- NCT05726344Sponsor investigatorN/AFeb 10, 2023
- NCT04358497Lead sponsorPhase 4Oct 1, 2020
- NCT04358497Reponsible party - principal investigatorPhase 4Oct 1, 2020
- NCT03180424Lead sponsorPhase 2/Phase 3Jan 1, 2017
- NCT03180424Reponsible party - principal investigatorPhase 2/Phase 3Jan 1, 2017
- NCT01750749Lead sponsorPhase 1May 1, 2011
- NCT01750749Reponsible party - principal investigatorPhase 1May 1, 2011
Details
- Last known activity
- Sep 30, 2025